<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 5 Issue 4</issue_number>
<issue_period>2014 (October - December)</issue_period>
<title>SYNTHESIS, REPRECIPITATION METHOD AND PHARMACOLOGICAL POTENCY OF FREE PORPHYRIN BASED NANOPARTICLES </title>
<abstract>We have designed and synthesized a new symmetrical porphyrins 3a-d and their nanoparticles based on extended  lessThan i greaterThan π lessThan /i greaterThan -conjugation concept. The new sensitizers were fully characterized by CHN analysis, UV-Vis.,  lessThan sup greaterThan 1 lessThan /sup greaterThan H-NMR, TEM and Mass spectroscopy. The new sensitizers and their nanoparticles were evaluated as antitumor activity against HepG2, WI-38, VERO and MCF-7 cell lines. It was found that porphyrin nanoparticles have the most potent activity.</abstract>
<authors>RASHA E. EL-MEKAWY  AND  SRAA ABU-MELHA</authors>
<keywords>Pyrrole, Porphyrin, porphyrin nanoparticles, Antitumor activity</keywords>
<pages>501-515</pages>
</article>
</Journal>
